Company Monitoring Page for Eli-Lilly

latest headlines for company on cafepharma

Researchers warn about gangrene cases in patients on SGLT2 diabetes drugs
Fierce Pharma
Thu, 05/9/19 - 11:04 pm
Tags:
gangrene, diabetes, JNJ, Invokana, AstraZeneca, Farxiga, Eli Lilly, Boehringer Ingelheim, Jardiance
Eli Lilly's Emgality shows positive Phase 3 results in treatment of migraine
Pharmafile
Wed, 05/8/19 - 05:39 pm
Tags:
Eli Lilly, migraines, clinical trials, Emgality
ED Drug Shows Promise in Sheep Heart Failure Study
BioSpace
Mon, 05/6/19 - 10:48 am
Tags:
heart failure, tadalafil, Pfizer, Viagra, Eli Lilly, Cialis
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
Xconomy
Sat, 05/4/19 - 04:54 pm
Tags:
migraines, CGRP blockers, Aimovig, Amgen, Ajovy, Teva Pharmaceutical, Emgality, Eli Lilly
Faint hope for Alder as Teva bucks dismal migraine trend
EP Vantage
Thu, 05/2/19 - 11:12 am
Tags:
migraines, Alder Biopharmaceuticals, Teva, Eli Lilly, Amgen, Emgality, Ajovy, eptinezumab
Express Scripts excludes Lilly's low cost insulin generic from preferred formulary
BioCentury
Wed, 05/1/19 - 11:46 pm
Tags:
Express Scripts, Eli Lilly, insulin, generics, PBMs
Incyte pulls away 'damaged goods' baricitinib to focus on internal pipeline
Endpoints
Tue, 04/30/19 - 08:57 pm
Tags:
Incyte, olumiant, baricitinib, FDA, Eli Lilly
Eli Lilly misses estimates for top-selling diabetes drug Trulicity, shares slip
Yahoo/Reuters
Tue, 04/30/19 - 09:39 am
Tags:
Eli Lilly, earnings
Express Scripts excludes Lilly's new low cost insulin generic
BioCentury
Fri, 04/26/19 - 07:40 pm
Tags:
Express Scripts, Eli Lilly, generics, diabetes, insulin, PBMs, Humalog
As it takes Lartruvo off the shelves, Lilly is setting up program to provide drug access to current patients
Endpoints
Thu, 04/25/19 - 12:00 pm
Tags:
Eli Lilly, Lartruvo, soft tissue sarcoma
What does the past generation of failure in Alzheimer’s R&D look like in one slide?
Endpoints
Wed, 04/24/19 - 11:45 am
Tags:
R&D, Alzheimer's disease, amyloid beta, Eli Lilly, Pfizer, JNJ
Lilly to sell legacy antibiotics, Ceclor and Vancocin, to China-based partner in $375M deal
Endpoints
Tue, 04/23/19 - 09:49 am
Tags:
Eli Lilly, China, antibiotics, Ceclor, Vancocin, Eddingpharm
Safety setback for Pfizer, Lilly pain drug should have Regeneron and Teva feeling nervous
Biopharma Dive
Mon, 04/22/19 - 03:37 pm
Tags:
Pfizer, Eli Lilly, painkillers, tanezumab, Regeneron, Teva Pharmaceutical, fasinumab
Lilly pays $35M up front to partner with Avidity on oligo conjugates
BioCentury
Mon, 04/22/19 - 10:24 am
Tags:
Eli Lilly, Avidity, oligo conjugates
Eli Lilly Falls Despite Positive Phase 3 Results From Taltz Study
TheStreet.com
Mon, 04/22/19 - 10:17 am
Tags:
Eli Lilly, axial spondyloarthritis, clinical trials, Taltz
Pfizer, Lilly to mull anti-NGF mAb's future after joint safety events spike in long-term readout
BioCentury
Fri, 04/19/19 - 05:57 pm
Tags:
Pfizer, Eli Lilly, tanezumab
BI and Lilly's diabetes drug Jardiance reverses heart failure in animal models
Fierce Biotech
Fri, 04/19/19 - 10:34 am
Tags:
Eli Lilly, Boehringer Ingelheim, Jardiance, type 2 diabetes, heart failure
Lower dose of Pfizer-Lilly painkiller misses main goals in late stage study
Yahoo/Reuters
Thu, 04/18/19 - 10:35 pm
Tags:
Pfizer, Eli Lilly, clinical trials, painkillers, osteoarthritis of the knee, tanezumab
The top 15 pharma companies by 2018 revenue
Fierce Pharma
Mon, 04/8/19 - 11:30 pm
Tags:
JNJ, Roche, Pfizer, Novartis, Merck, GSK, Sanofi, AbbVie, Bayer, Eli Lilly, Amgen, Bristol-Myers Squibb, Gilead Sciences, Teva Pharmaceutical, AstraZeneca
Big Pharma come together for better drug side effect detection
Pharma Times
Sun, 04/7/19 - 05:18 pm
Tags:
side effects, adverse events, Pfizer, Roche, Takeda, Eli Lilly, Bristol-Myers Squibb, Gilead Sciences, Alexion, Celgene, International Working Group on Signal Detection and Management in Pharmacovigilance, pharmacovigilance

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.